A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR
CVR 27908047 · Public limited company (A/S) · Active · Low risk
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR is a Public limited company (A/S), founded on , based in København K. The company is registered in the industry anden finansiel formidling i.a.n.. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.5m and a net result of DKK -3,000. CEO: Ahmet Turan Kayhan.
Bankruptcy risk for A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR
0.1%
probability of bankruptcy within 12 months
Low risk
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Lowest riskHighest risk
Increases the risk
Reporting classReporting class B, mikrovirksomhed · bankruptcy rate 23.5%2.7×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Reduces the risk
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Company typeA/S · bankruptcy rate 4.4%0.50×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 27908047
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (22 years)
- Address
- c/o BI Holding A/S, Bredgade 40
1260 København K - Municipality
- København
- Industry
- Anden finansiel formidling i.a.n. (649990)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 2.0m
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 22 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 12 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 90 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Net profit | DKK -3,000 | DKK 2,000 |
| Equity | DKK 2.5m | DKK 2.5m |
| Total assets | DKK 2.5m | DKK 2.5m |
| Cash | DKK 2.5m | – |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 146 | ||
| 1 Jan 2024 – 31 Dec 2024 | 115 | ||
| 1 Jan 2023 – 31 Dec 2023 | 151 | ||
| 1 Jan 2022 – 31 Dec 2022 | 171 | ||
| 1 Jan 2021 – 31 Dec 2021 | 145 | ||
| 1 Jan 2020 – 31 Dec 2020 | 113 | ||
| 1 Jan 2019 – 31 Dec 2019 | 111 | ||
| 1 Jan 2018 – 31 Dec 2018 | 128 | ||
| 1 Jan 2017 – 31 Dec 2017 | 137 | ||
| 1 Jan 2016 – 31 Dec 2016 | 130 | ||
| 1 Jan 2015 – 31 Dec 2015 | 141 | ||
| 1 Jan 2014 – 31 Dec 2014 | 114 | ||
| 1 Jan 2013 – 31 Dec 2013 | 101 | ||
| 1 Jan 2012 – 31 Dec 2012 | 127 | ||
| 1 Jan 2011 – 31 Dec 2011 | 150 | ||
| 1 Jan 2010 – 31 Dec 2010 | 135 | ||
| 1 Jan 2009 – 31 Dec 2009 | 124 | ||
| 1 Jan 2008 – 31 Dec 2008 | 153 | ||
| 1 Jan 2007 – 31 Dec 2007 | 163 | ||
| 1 Jan 2006 – 31 Dec 2006 | 178 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Ahmet Turan Kayhan | Current | |
| CEO | Jesper Zeuthen | ||
| CEO | Thomas Tscherning | ||
| CEO | Kenneth Bering Hansen | ||
| CEO | Lars Thomas Gunnarsson | ||
| CEO | Sanne Fredenslund | ||
| CEO | Kurt Hangaard | ||
| Board | Andrea Panzieri | Current | |
| Board | Ahmet Turan Kayhan | Current | |
| Board | Allan Funk Nissen | Current | |
| Board | Niels Burtenshaw Thuesen | ||
| Board | Nils Hougaard Christensen | ||
| Board | Bjarne Thorup | ||
| Board | Torben Arnth Nielsen | ||
| Board | Kenneth Bering Hansen | ||
| Board | Mikael Kortegaard Larsen | ||
| Board | Lars Thomas Gunnarsson | ||
| Board | Sanne Fredenslund | ||
| Board | Kurt Hangaard | ||
| Owner (100%) | BI HOLDING A/S | Current | |
| Auditor | CJ Partnership I/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | BI HOLDING A/S | Current |
The CEOs' other companies
Jesper Zeuthen – 17 other companies, of which 1 bankrupt
- UDVIKLINGSSELSKABET LP AF 11. JANUAR 2001 A/S Bankrupt 2 Dec 2009
- A/S BI BIOMEDICINSK VENTURE III KOMPLEMENTAR Opløst
- AGC Biologics A/S Active
- AKTIESELSKABET BI BIOMEDICINSK VENTURE II Opløst
- BANKINVEST PRIVATE EQUITY A/S Opløst
- BIOVISION A/S Opløst
- BOREAN PHARMA ApS Opløst
- GENMAB A/S Active
- INPROTHER ApS Active
- KUROS HOLDING ApS Opløst
- PROTEOPHARMA ApS Opløst
- RICC A/S Active
- ROCHE BIO DENMARK A/S Opløst
- Renovaro Biosciences Denmark ApS Active
- TOPOTARGET A/S Fusioneret
- ZEALAND PHARMA A/S Active
- ZYMENEX HOLDING ApS Opløst
Thomas Tscherning – 15 other companies, of which 1 bankrupt
- MYLVL ApS Bankrupt 25 Nov 2016
- A/S BI BIOMEDICINSK VENTURE III KOMPLEMENTAR Opløst
- ACE BIOSCIENCES ApS Fusioneret
- AGC Biologics A/S Active
- AKTIESELSKABET BI BIOMEDICINSK VENTURE II Opløst
- BANKINVEST PRIVATE EQUITY A/S Opløst
- BOREAN PHARMA ApS Opløst
- DANISH BIOVENTURE GENERAL PARTNER ApS Opløst
- Elenchos ApS Active
- Mokuaina Holding ApS Active
- ROCHE BIO DENMARK A/S Opløst
- TOPOTARGET A/S Fusioneret
- ZEALAND PHARMA A/S Active
- ZYMENEX ApS Fusioneret
- ZYMENEX HOLDING ApS Opløst
Kenneth Bering Hansen – 14 other companies
- A/S BI BIOMEDICINSK VENTURE III KOMPLEMENTAR Opløst
- A/S BI IT VENTURE 1 Opløst
- A/S NEW ENERGY SOLUTIONS KOMPLEMENTAR Opløst
- BANKINVEST PRIVATE EQUITY A/S Opløst
- BI INVEST A/S Opløst
- NES II GP A/S Opløst
- NES II GP HOLDING A/S Opløst
- NES II PARTNER HOLDING A/S Opløst
- PENM I GP HOLDING A/S Opløst
- PENM I INVEST A/S Opløst
- PENM I PARTNER HOLDING A/S Opløst
- PENM II GP HOLDING A/S Opløst
- PENM II INVEST A/S Opløst
- PENM III INVEST A/S Opløst
Lars Thomas Gunnarsson – 7 other companies
- BANKINVEST PRIVATE EQUITY A/S Opløst
- GARANTI INVEST A/S Opløst
- PENM I GP HOLDING A/S Opløst
- PENM I INVEST A/S Opløst
- PENM I PARTNER HOLDING A/S Opløst
- PENM II INVEST A/S Opløst
- Svanemølleholmen Invest A/S Active
Sanne Fredenslund – 8 other companies
- BANKINVEST PRIVATE EQUITY A/S Opløst
- BI Erhvervsejendomme A/S Active
- DANBOLIG A/S Active
- FIONIA ASSET COMPANY A/S Active
- Nordea Pension, Livsforsikringsselskab A/S Active
- PENM I GP HOLDING A/S Opløst
- PENM I INVEST A/S Opløst
- PENM II INVEST A/S Opløst
Kurt Hangaard – 6 other companies
- BANKINVEST PRIVATE EQUITY A/S Opløst
- BI Erhvervsejendomme A/S Active
- Hangaard Holding ApS Opløst
- PENM I GP HOLDING A/S Opløst
- PENM I INVEST A/S Opløst
- PENM II INVEST A/S Opløst
Address history (1 moves)
| c/o BI Holding A/S, Bredgade 40, 1260 København K | |
| c/o BI Holding A/S, Sundkrogsgade 7, 2100 København Ø |
Other companies at the same address
- 22. november 2021 ApS Active
- ADVANTAGE Core Infrastruktur DCP VII 2022 I A/S Active
- ADVANTAGE Core Infrastruktur DCP VII 2022 II A/S Active
- ADVANTAGE Core Infrastruktur DCP VII 2022 III A/S Active
- ADVANTAGE Investment Partners A/S Active
- ADVANTAGE PE 2019 A GP ApS Active
- ADVANTAGE PE 2019 Feeder ApS Active
- ADVANTAGE Private Equity 2020 I GP ApS Active
- ADVANTAGE Private Equity 2020 II A/S Active
- ALTOR EQUITY PARTNERS A/S Active
- AWL HoldCo I - Sydhavnen ApS Active
- Advantage Club GP II ApS Active
- Advantage Club GP ApS Active
- BANKINVEST PRIVATE EQUITY A/S Opløst
- BFL HoldCo I - Hvidovre ApS Active
- BFL HoldCo II - Smørum ApS Active
- BFL HoldCo III - Ishøj ApS Active
- BFL HoldCo IV - Albertslund ApS Active
- BFL HoldCo V - Bagsværd ApS Active
- BFL HoldCo VI - Glostrup ApS Active
- BFL PropCo I - Hvidovre ApS Active
- BFL PropCo II - Smørum ApS Active
- BFL PropCo III - Ishøj ApS Active
- BFL PropCo V - Bagsværd ApS Active
- BFL PropCo VI - Glostrup ApS Active
Similar companies in København
- Axcel CV GP ApS København Ø
- CC Aviation General Partner I ApS København Ø
- GL 1 Komplementar ApS København V
- AYA Asset Management FAIF ApS København K
- PL GP ApS København V
- Verdi Management ApS København K
- ImproveInvest A/S Hellerup
- MIM II GP ApS København K
- RockBio Venture ApS København S
- CSF-I 3 GP ApS København Ø
- DSDG II GP Komplementar ApS København Ø
- RoseTreeGroup ApS København K
Questions and answers about A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR
Has A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR gone bankrupt?
No, A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR?
Ahmet Turan Kayhan is the CEO of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR.
When was A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR founded?
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR was founded on 2 June 2004.
What is the equity of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR?
Equity was DKK 2.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.